Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:34:33 UTC |
---|
Update Date | 2021-09-26 23:00:46 UTC |
---|
HMDB ID | HMDB0249724 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide |
---|
Description | 12-chloro-9-(2-chlorophenyl)-2,4,8-triazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaene-5-carboximidic acid belongs to the class of organic compounds known as imidazo[1,5-a][1,4]benzodiazepines. Imidazo[1,5-a][1,4]benzodiazepines are compounds containing an imidazole ring and a 1,4-benzodiazepine ring system, both sharing one nitrogen atom. Based on a literature review very few articles have been published on 12-chloro-9-(2-chlorophenyl)-2,4,8-triazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaene-5-carboximidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). 8-chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | NC(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N2C=N1 InChI=1S/C18H12Cl2N4O/c19-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)20)22-8-15-17(18(21)25)23-9-24(14)15/h1-7,9H,8H2,(H2,21,25) |
---|
Synonyms | Value | Source |
---|
12-Chloro-9-(2-chlorophenyl)-2,4,8-triazatricyclo[8.4.0.0,]tetradeca-1(10),3,5,8,11,13-hexaene-5-carboximidate | Generator | 8-Chloro-6-(2-chlorophenyl)-4H-imidazo(1,5-a)(1,4)-benzodiazepine-3-carboxamide | MeSH | CCIBC | MeSH |
|
---|
Chemical Formula | C18H12Cl2N4O |
---|
Average Molecular Weight | 371.22 |
---|
Monoisotopic Molecular Weight | 370.0388164 |
---|
IUPAC Name | 12-chloro-9-(2-chlorophenyl)-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene-5-carboxamide |
---|
Traditional Name | 12-chloro-9-(2-chlorophenyl)-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene-5-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | NC(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N2C=N1 |
---|
InChI Identifier | InChI=1S/C18H12Cl2N4O/c19-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)20)22-8-15-17(18(21)25)23-9-24(14)15/h1-7,9H,8H2,(H2,21,25) |
---|
InChI Key | CXMABIICIXUMKC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as imidazo[1,5-a][1,4]benzodiazepines. Imidazo[1,5-a][1,4]benzodiazepines are compounds containing an imidazole ring and a 1,4-benzodiazepine ring system, both sharing one nitrogen atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | Imidazo[1,5-a][1,4]benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - Imidazo[1,5-a][1,4]benzodiazepine
- 2-heteroaryl carboxamide
- Para-diazepine
- Halobenzene
- Imidazole-4-carbonyl group
- Chlorobenzene
- Aryl chloride
- Aryl halide
- N-substituted imidazole
- Monocyclic benzene moiety
- Benzenoid
- Azole
- Imidazole
- Heteroaromatic compound
- Vinylogous amide
- Primary carboxylic acid amide
- Ketimine
- Carboxamide group
- Azacycle
- Organic 1,3-dipolar compound
- Carboxylic acid derivative
- Propargyl-type 1,3-dipolar organic compound
- Organooxygen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organonitrogen compound
- Imine
- Organochloride
- Organohalogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1 | 3292.6 | Semi standard non polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1 | 3266.3 | Standard non polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1 | 4888.9 | Standard polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1)[Si](C)(C)C | 3250.5 | Semi standard non polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1)[Si](C)(C)C | 3392.9 | Standard non polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1)[Si](C)(C)C | 4451.0 | Standard polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1 | 3444.1 | Semi standard non polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1 | 3500.0 | Standard non polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1 | 4888.2 | Standard polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1)[Si](C)(C)C(C)(C)C | 3580.4 | Semi standard non polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1)[Si](C)(C)C(C)(C)C | 3825.6 | Standard non polar | 33892256 | 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N2C=N1)[Si](C)(C)C(C)(C)C | 4400.1 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0f96-4019000000-a100b508f56903754296 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide 10V, Positive-QTOF | splash10-00di-0009000000-637fe635d1ec9d49fd0e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide 20V, Positive-QTOF | splash10-0fk9-0009000000-f5a85db8f0141eb8cba5 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide 40V, Positive-QTOF | splash10-0udi-0009000000-68e7199d4c5887500b4a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide 10V, Negative-QTOF | splash10-00or-0019000000-6f11598ac503174a5fa5 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide 20V, Negative-QTOF | splash10-004i-0009000000-6c2bc724e48a69e9daaa | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide 40V, Negative-QTOF | splash10-016r-0059000000-b87d0979ca702b9e5cf8 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|